Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Aptevo Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −2 vs. Q2 2021
- Shares held
- 2.73M
- −181.1K (−6.2%) vs. Q2 2021
- Total value
- $42.1M
- −$23.1M (−35.5%) vs. Q2 2021
- New holders
- 6
- 6 more added
- Sold out
- 8
- 3 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $224.3K |
| Q1 2026 | 9 | $229.7K |
| Q4 2025 | 11 | $191.4K |
| Q3 2025 | 12 | $717.1K |
| Q2 2025 | 7 | $45.9K |
| Q1 2025 | 8 | $22.8K |
| Q4 2024 | 13 | $208.7K |
| Q3 2024 | 19 | $231.1K |
| Q2 2024 | 18 | $599.1K |
| Q1 2024 | 10 | $12.4K |
| Q4 2023 | 29 | $349.7K |
| Q3 2023 | 26 | $1.13M |
| Q2 2023 | 23 | $1.36M |
| Q1 2023 | 24 | $1.82M |
| Q4 2022 | 27 | $2.27M |
| Q3 2022 | 27 | $2.63M |
| Q2 2022 | 27 | $2.85M |
| Q1 2022 | 24 | $4.76M |
| Q4 2021 | 23 | $5.99M |
| Q3 2021 | 26 | $42.1M |
| Q2 2021 | 29 | $65.5M |
| Q1 2021 | 34 | $89.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Aptevo Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 1,760,000 | $27.2M | 5.64% | 00.0% | Unchanged |
| RTW Investments, LP | 281,402 | $4.34M | 0.07% | 00.0% | Unchanged |
| Towercrest Capital Management | 211,227 | $3.26M | 0.62% | +211,227 | New |
| Renaissance Technologies LLC | 143,419 | $2.21M | 0.00% | −16,504−10.3% | Reduced |
| Vanguard Group Inc | 135,272 | $2.09M | 0.00% | +512+0.4% | Added |
| BlackRock Inc. | 55,394 | $856.0K | 0.00% | +1,010+1.9% | Added |
| Geode Capital Management, LLC | 39,924 | $616.0K | 0.00% | +1,007+2.6% | Added |
| Northern Trust Corp | 22,751 | $351.0K | 0.00% | +99+0.4% | Added |
| Franklin Resources Inc | 15,650 | $242.0K | 0.00% | +15,650 | New |
| Boothbay Fund Management, LLC | 15,350 | $237.0K | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 13,651 | $211.0K | 0.02% | +13,651 | New |
| Morgan Stanley | 11,028 | $170.0K | 0.00% | +2,664+31.9% | Added |
| State Street Corp | 10,973 | $169.0K | 0.00% | 00.0% | Unchanged |
| JBF Capital, Inc. | 3,907 | $60.0K | 0.01% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,614 | $25.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,552 | $24.0K | 0.00% | −2−0.1% | Reduced |
| Tower Research Capital LLC (TRC) | 1,194 | $18.0K | 0.00% | +1,194 | New |
| Fifth Third Bancorp | 291 | $4.00K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 218 | $3.00K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 142 | $2.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 95 | $1.00K | 0.00% | −42−30.7% | Reduced |
| US Bancorp | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 29 | $0 | 0.00% | +20+222.2% | Added |
| Citigroup Inc | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Earnest Partners LLC | 14 | $0 | 0.00% | +14 | New |
| Advisor Group Holdings, Inc. | 30 | $0 | 0.00% | +30 | New |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −187,995−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −139,172−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −35,587−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −18,012−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −14,022−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,821−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| QS Investors, LLC | – | – | – | – | Not filed |